US 7344711
Use of adenoviruses mutated in the VA genes for cancer treatment
granted A61KA61K35/761A61K48/00
Quick answer
US patent 7344711 (Use of adenoviruses mutated in the VA genes for cancer treatment) held by ONCOLYTICS BIOTECH INC. expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K35/761, A61K48/00, A61P, A61P35/00